Patents by Inventor Jitka Soukupova

Jitka Soukupova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-BENZOYLAMINOBENZAMIDE DERIVATIVES AS BCL-3 INHIBITORS
    Publication number: 20220017478
    Abstract: The invention relates to a compound of general formula (I): wherein R1, R2, R3, R4, Q, m and n are as defined herein. The compounds are inhibitors of Bcl3 and are useful for the treatment of cancer, particularly metastatic cancer.
    Type: Application
    Filed: September 29, 2021
    Publication date: January 20, 2022
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson, Jitka Soukupova
  • 2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors
    Patent number: 11180466
    Abstract: The invention relates to a compound of general formula (I): wherein R1, R2, R3, R4, Q, m and n are as defined herein. The compounds are inhibitors of Bcl-3 and are useful for the treatment of cancer, particularly metastatic cancer.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: November 23, 2021
    Assignee: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson, Jitka Soukupova
  • 2-BENZOYLAMINOBENZAMIDE DERIVATIVES AS BCL-3 INHIBITORS
    Publication number: 20200031787
    Abstract: The invention relates to a compound of general formula (I): wherein R1, R2, R3, R4, Q, m and n are as defined herein. The compounds are inhibitors of Bcl-3 and are useful for the treatment of cancer, particularly metastatic cancer.
    Type: Application
    Filed: October 4, 2019
    Publication date: January 30, 2020
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson, Jitka Soukupova
  • 2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors
    Patent number: 10450285
    Abstract: The invention relates to a compound of general formula (I): wherein R1, R2, R3, R4, Q, m and n are as defined herein. The compounds are inhibitors of Bcl3 and are useful for the treatment of cancer, particularly metastatic cancer.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: October 22, 2019
    Assignee: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson, Jitka Soukupova
  • 2-BENZOYLAMINOBENZAMIDE DERIVATIVES AS BCL-3 INHIBITORS
    Publication number: 20160185740
    Abstract: The invention relates to a compound of general formula (I): wherein R1, R2, R3, R4, Q, m and n are as defined herein. The compounds are inhibitors of Bcl3 and are useful for the treatment of cancer, particularly metastatic cancer.
    Type: Application
    Filed: July 31, 2014
    Publication date: June 30, 2016
    Inventors: Andrew David Westwell, Andrea Brancale, Richard William Ernest Clarkson, Jitka Soukupova